a<p>Number of studies.</p>b<p>P value of Q-test for heterogeneity test.</p>c<p>Random-effects model was used when a P value <0.05 for heterogeneity test; otherwise, fixed-effects model was used.</p><p><i>I</i><sup>2</sup> 0–25, no heterogeneity; 25–50, modest heterogeneity; 50 high heterogeneity.</p
1<p>all summary ORs were calculated using fixed-effects models. In the case of significant heterogen...
<p>PCR-RFLP: restriction fragment length polymorphism.</p>a<p>Number of comparisons.</p>b<p><i>P</i>...
<p>n: number of studies.</p><p><sup>a</sup>Test for heterogeneity.</p><p><sup>b</sup>Fixed-effect mo...
a<p>P value of Q-test for heterogeneity test.</p>b<p>Random-effects model was used when a P value<0....
a<p>P value of Q-test for heterogeneity test.</p>b<p>Random-effects model was used when a P value<0....
a<p>P value of Q-test for heterogeneity test.</p>b<p>Random-effects model was used when a P value<0....
a<p>Number of comparisons.</p>b<p>P value of Q-test for heterogeneity test.</p>c<p>Random-effects mo...
a<p>Number of studies.</p><p><b><i>I</i></b><b><sup>2</sup></b>The value of heterogeneity test.</p>c...
a<p>Contains two HNC and one CRC studies.</p>b<p>Number of comparisons. One of these studies consist...
a<p>Number of comparisons.</p>b<p><i>P</i> value of <i>Q</i>-test for heterogeneity test.</p>c<p>Ran...
1<p>All summary ORs were calculated using fixed-effects models. In the case of significant heterogen...
1<p>All summary ORs were calculated using fixed-effects models. In the case of significant heterogen...
1<p>All summary ORs were calculated using fixed-effects models. In the case of significant heterogen...
<p>HCC: hepatocellular carcinoma.</p>a<p>Number of included studies.</p>b<p><i>P</i> value of <i>Q</...
<p><sup>a</sup>: Number of studies.</p><p><sup>b</sup>: Fix-effects model was used when <i>I</i><sup...
1<p>all summary ORs were calculated using fixed-effects models. In the case of significant heterogen...
<p>PCR-RFLP: restriction fragment length polymorphism.</p>a<p>Number of comparisons.</p>b<p><i>P</i>...
<p>n: number of studies.</p><p><sup>a</sup>Test for heterogeneity.</p><p><sup>b</sup>Fixed-effect mo...
a<p>P value of Q-test for heterogeneity test.</p>b<p>Random-effects model was used when a P value<0....
a<p>P value of Q-test for heterogeneity test.</p>b<p>Random-effects model was used when a P value<0....
a<p>P value of Q-test for heterogeneity test.</p>b<p>Random-effects model was used when a P value<0....
a<p>Number of comparisons.</p>b<p>P value of Q-test for heterogeneity test.</p>c<p>Random-effects mo...
a<p>Number of studies.</p><p><b><i>I</i></b><b><sup>2</sup></b>The value of heterogeneity test.</p>c...
a<p>Contains two HNC and one CRC studies.</p>b<p>Number of comparisons. One of these studies consist...
a<p>Number of comparisons.</p>b<p><i>P</i> value of <i>Q</i>-test for heterogeneity test.</p>c<p>Ran...
1<p>All summary ORs were calculated using fixed-effects models. In the case of significant heterogen...
1<p>All summary ORs were calculated using fixed-effects models. In the case of significant heterogen...
1<p>All summary ORs were calculated using fixed-effects models. In the case of significant heterogen...
<p>HCC: hepatocellular carcinoma.</p>a<p>Number of included studies.</p>b<p><i>P</i> value of <i>Q</...
<p><sup>a</sup>: Number of studies.</p><p><sup>b</sup>: Fix-effects model was used when <i>I</i><sup...
1<p>all summary ORs were calculated using fixed-effects models. In the case of significant heterogen...
<p>PCR-RFLP: restriction fragment length polymorphism.</p>a<p>Number of comparisons.</p>b<p><i>P</i>...
<p>n: number of studies.</p><p><sup>a</sup>Test for heterogeneity.</p><p><sup>b</sup>Fixed-effect mo...